Quercetin mediated reduction of angiogenic markers and chaperones in DLA-induced solid tumours

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 2829-2835

  Anand, Kushi ^a   Asthana, Pallavi ^a   Kumar, Anup ^a   Ambasta, Rashmi K ^a   Kumar, Pravir ^a,b  

^a VIT UNIVERSITY   (India)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; DLA; Heat shock proteins; HIF 1 ; Quercetin; VEGF

Indexed keywords

EID: 84863318870     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Avila MA, Velasco JA, Cansado J, Notario V (1994). Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res, 54, 2424-8.
2. Carmeliet P, Jain RK (2000). Angiogenesis in cancer and other diseases. Nature, 407, 249-57.
3. Ciocca DR, Calderwood SK (2005). Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones, 10, 86-103.
4. Ciocca DR, Clark GM, Tandon AK, et al (1993). Heat shock protein hsp70 in patients with axillary lymph node negative breast cancer: prognostic implications. J Natl Cancer Inst, 85, 570-4.
5. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA (1993). Biological and clinical implications of heat shock protein27000 (Hsp27): a review. J Natl Cancer Inst, 85, 1558-70.
6. Dachs GU, Patterson AV, Firth JD, et al (1997). Targeting gene expression to hypoxic tumor cells. Nat Med, 3, 515-20.
7. Doll R, Peto R (1981). The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst, 66, 1191-308.
8. Elmore S (2007). Apoptosis: A review of programmed cell death. Toxicol Pathol, 35, 495-16.
9. Folkman J (1990). What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Ins, 82, 4-6.
10. Fuqua SA, Oesterreich S, Hilsenbeck SG et al (1994). Heat shock proteins and drug resistance. Breast Cancer Res Treat, 32, 67-71.
11. Giommarelli C, Zuco V, Favini E, et al (2010). The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition. Cell Mol Life Sci, 67, 995-1004.
12. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z (1993). The cell cycle related difference in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res, 53, 3186-92.
13. Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S (2006). Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK path- ways in a human hepatoma cell line (HepG2). J Nutr, 136, 2715-21.
14. Hajra KM, Liu JR (2004). Apoptosome dysfunction in human cancer. Apoptosis, 9, 691-704.
15. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
16. Hertog MGL, Hollman PCH, Katan MB (1992). The content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem, 40, 2379-83
17. Hirsch T, Marchetti P, Susin SA, et al (1997). The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene, 15, 1573-81.
18. Hosokawa N, K Hirayoshi, Kudo H, et al (1992). Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol Cell Biol, 12, 3490-8.
19. Husain SR, Kreitman RJ, Pastan I, Puri RK (1999). Interleukin-4receptor directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model. Nat Med, 5, 817-22.
20. Isaacs JS, Jung YJ, Mimnaugh EG, et al (2002). Hsp90 regulates a von Hippel-Lindau independent hypoxia-inducible factor-1α-degradative pathway. J Biol Chem, 277, 29936-44.
21. Jaattela M (1999). Escaping cell death: Survival proteins in cancer. Exp Cell Res, 248, 30-43.
22. Jaattela M, Wissing D (1993). Heat-shock proteins protect cells from monocyte cytotoxicity: Possible mechanism of self-protection. J Exp Med, 177, 231-6.
23. Jaattela M, Wissing D, Bauer PA, Li GC (1992). Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J, 11, 3507-12.
24. Jakubowicz-Gil J, Rzymowska J, Gawron A (2002). Quercetin, apoptosis, heat shock. Biochem Pharmacol, 64, 1591-5.
25. Jeon H, Kim H, Choi D, et al (2007). Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: A structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase. Mol Pharmacol, 71, 1676-84.
26. Kang MS, Gao KP, Morris T, et al (2004). Comparison of inhibition of angiogenesis and expression of VEGF and avβ3 in CAM angiogenesis mode. Cellular, Molecular, and Tumor Biol. 2, Abstract # 73: Angiogenesis Inhibitors II. Proc Am Assoc Cancer Res, 45, 17.
27. Katschinski DM, Le L, Heinrich D, et al (2002). Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activty. J Biol Chem, 277, 9262-7.
28. Lamson DW, Brignall MS (2000). Antioxidants and cancer, part 3: quercetin. Altern. Med Rev, 5, 196-208.
29. Larocca LM, Teofili L, Sica S, et al (1995). Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells. Blood, 85, 3654-61.
30. Lee DH, Lee YJ (2008). Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. J Cell Biochem, 105, 546-53.
31. Mizukami Y, Kohgo Y, Chung DC (2007). Hypoxia inducible factor-1-independent pathways in tumor angiogenesis. Clin Cancer Res, 13, 5670-4.
32. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. (1997). Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol, 17, 5317-27.
33. Nanbu K, Konishi I, Mandai M, et al (1998). Prognostic Significance of Heat Shock Proteins Hsp70 and Hsp90 In Endometrial Carcinomas. Cancer Detect Prev, 22, 549-55.
34. Peng XH, Karna P, Cao Z, et al (2006). Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor- 1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem, 281, 25903-14.
35. Prajda N, Singhal RL, Yeh YA, et al (1995). Linkage of reduction in 1 phosphatidylinositol 4-kinase activity and inositol 1, 4, 5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. Life Sci, 56, 1587-93.
36. Preethi KC, Kuttan G, Kuttan R (2006). Anti-tumour activity of Ruta graveolens extract. Asian Pac J Cancer Prev, 7, 439-43.
37. Ralhan R, Kaur J (1995). Differential expression Mr 70,000 heat shock protein in normal, premalignant, and malignant human uterine cervix. Clin Cancer Res, 1, 1217-22.
38. Rane MJ, Pan Y, Singh S, et al (2003). Heat shock protein 27 controls apoptosis by regulating Akt activation. J Biol Chem, 278, 27828-35.
39. Ranelletti FO, Ricci R, Larocca LM, et al (1992). Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer, 50, 486-92.
40. Rice-Evans CA, Miller NJ, Paganga G, (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med, 20, 933-56.
41. Rong Y, Yang EB, Zhang K, Mack P (2000). Quercetin-induced apoptosis in the monoblastoid cell line U937 in vitro and the regulation of heat shock proteins expression. Anticancer Res, 20, 4339-45.
42. Semenza GL (1998). Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev, 8, 588-94.
43. Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-32.
44. Staufer K, Stoeltzing O (2010). Implication of heat shock protein 90 (HSP90) in tumor angiogenesis: a molecular target for anti-angiogenic therapy. Curr Cancer Drug Targets, 10, 890-7.
45. Tadjalli-Mehr K, Becker N, Rahu M, et al (2003). Randomized trial with fruits and vegetables in prevention of cancer. Acta Oncol, 42, 287-93.
46. Tanimoto K, Makino Y, Pereira T, Poellinger L (2000). Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J, 19, 4298-309.
47. Trepel J, Mollapour M, Giaccone G, Neckers L (2010). Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer, 10, 537-49.
48. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR (1998). Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer, 79, 468-75.
49. Whitesell L, Lindquist SL (2005). HSP90 and the chaperoning of cancer. Nat Rev Cancer, 5, 761-72.
50. Wilson WJ, Poellinger L (2002). The dietary flavonoid quercetin modulatesHIF-1 alpha activity in endothelial cells. Biochem Biophys Res Commun, 293, 446-50
51. Xiao X, Shi D, Liu L, et al (2011). Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS ONE, 6, e22934.
52. Zhang H, Chung D, Yang YC, et al (2006). Identification of new biomarkers for clinical trials of Hsp90 inhibitors. Mol Cancer Ther, 5, 1256-64.